TECHNICAL FIELD
The invention relates to a pharmaceutical composition comprising canavanine, and a method treatment of cancer, particularly pancreatic cancer, with L-canavanine.
BACKGROUND
More than 26,000 people die each year in our country from pancreatic adenocarcinoma (1, see numbered references
TECHNICAL FIELD
The invention relates to a pharmaceutical composition comprising canavanine analogs, and a method of treatment of cancer, particularly pancreatic cancer, with canavanine analogs.
BACKGROUND
L-Canavanine [L-2-amino-4-(guanidinooxy)butyric acid], a nonprotein amino acid found in